MISSION
Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other individuals who embody our values: care, be real, get it done, and have fun, seriously.
POSITION SUMMARY
The Senior Product Marketing Manager, Bile Acid Portfolio, will play a critical support role to the Marketing Director in the strategic and tactical execution of marketing initiatives for CTEXLI™ and CHOLBAM®. This individual will help plan, coordinate, and implement key brand activities across digital, field, patient, and healthcare provider channels.
This role is ideal for a motivated, resourceful, and digitally-savvy professional who is eager to learn, take ownership of meaningful projects, and grow within a high-performing, mission-driven commercial team.
JOB FUNCTIONS/RESPONSIBILITIES
Brand & Marketing Support
- Partner with the Marketing Director to execute the annual brand plans for CTEXLI and CHOLBAM.
- Assist in developing marketing materials (HCP, patient/caregiver, digital) in alignment with strategic objectives and compliance standards.
- Support execution of omnichannel marketing initiatives, including HCP and patient campaigns, digital content, CRM/email marketing, and social media.
- Coordinate review and approval (MLR) processes, ensuring materials are accurate, timely, and compliant.
- Support tactical execution of field force tools and branded and unbranded education initiatives.
- Manage creative and digital agency partners, ensuring deliverables are high-quality, compliant, and on-time.
- Support ongoing field team enablement through tools, resources, and internal communications.
- Maintain awareness of emerging digital tools and rare disease engagement innovations.
- Help maintain brand budgets and timelines.
- Coordinate logistics for congresses, speaker programs, and HCP & patient events.
- Prepare summaries, presentations, and reports for leadership and brand review meetings.
- Work closely with cross-functional partners (Medical Affairs, Market Access, Patient Services, Commercial Operations, and Field Teams) to ensure alignment and seamless execution.
Qualifications
Education & Experience
- Bachelor’s degree in business, marketing, life sciences, or related field required
- 5+ years of experience in pharmaceutical marketing, product management, or commercial operations, ideally in rare disease.
Knowledge, Skills and Abilities:
- Strong organizational, project management, and communication skills.
- High attention to detail with ability to manage multiple priorities and deadlines.
- Digital fluency – comfortable with CRM systems, analytics platforms, and digital campaign tools.
- Analytical mindset – able to synthesize data and insights to inform decisions.
- Collaborative, flexible, and proactive – thrives in a dynamic, fast-paced environment.
- Passionate about helping patients with rare diseases and driven by purpose.
- Resourceful and eager to learn – a self-starter who takes ownership and seeks opportunities for growth.
- Graphic design and experience with Adobe Creative Cloud (InDesign, Photoshop, etc.) a plus.
#LI-HYBRID
Mirum Pharmaceuticals is committed to Equal Employment Opportunity (EEO) and to compliance with all Federal, State and Local laws that prohibit employment discrimination on the basis of race, age, national origin, ethnicity, religion, gender, gender identity, pregnancy, marital status, sexual orientation, citizenship, genetic disposition or characteristics, disability, veteran’s status or any other classification protected by applicable State/Federal/Local laws.
Mirum Pharmaceuticals provides reasonable accommodation for qualified individuals with disabilities and disabled veterans in job application procedures.
Top Skills
What We Do
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. Mirum’s approved medication is LIVMARLI® (maralixibat) oral solution which is approved in the U.S. for the treatment of cholestatic pruritus in patients with Alagille syndrome one year of age and older.
Mirum’s late-stage pipeline includes two investigational treatments for debilitating liver diseases affecting children and adults. Maralixibat (LIVMARLI), an oral ileal bile acid transporter (IBAT) inhibitor, is currently being evaluated in clinical trials for pediatric liver diseases and includes the MARCH Phase 3 study for progressive familial intrahepatic cholestasis (PFIC) and the EMBARK Phase 2b study for patients with biliary atresia. In addition, Mirum has an expanded access program open in Canada, Australia, the UK and several countries in Europe for eligible patients with Alagille syndrome.
Mirum has submitted a Marketing Authorization Application to the European Medicines Agency for maralixibat for the treatment of cholestatic liver disease in patients with Alagille syndrome.
Mirum’s second investigational treatment, volixibat, also an oral IBAT inhibitor, is being evaluated in three potentially registrational studies including the OHANA Phase 2b study for pregnant women with intrahepatic cholestasis of pregnancy, VISTAS Phase 2b study for adults with primary sclerosing cholangitis, and the VANTAGE Phase 2b study for primary biliary cholangitis.
.png)
